XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Receivables

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) currently reports a receivables of $23M as of March 2026. That compares with $5.5M in the prior-year period — up 320.6% year over year. Use the charts on this page to explore XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's receivables history and peer comparisons.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's receivables increased from $5.5M to $23M — a 320.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A reported $23M in receivables as of March 2026. That compares with $5.5M in the prior-year period — up 320.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A, and consider following XOMAP for alerts when major investors trade the stock.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On receivables, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XOMAP with unrelated industries.